Researchers find that proteins in the blood help assess prostate cancer risk. buff.ly/KTn4FIb

Join us on Nov. 5th for Emerging Tools for Functional Cell Sorting, an educational virtual event exploring how new large-particle workflows are expanding the possibilities of flow cytometry-based analysis and sorting. Register now: buff.ly/CnuoOqt

Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/IG6Pwv0

Scientists outline complex molecular pathway, providing insights into novel therapeutic targets to overcome cancer. buff.ly/XNoZzC0

A new study finds important prognostic value from a single photo of an individual’s face. buff.ly/xXGPTuC

The ovary has long been treated as an inert organ once menopause is over. 👵 A proteomic analysis of 28 donated ovaries found that they keep changing for decades afterward. 🔎 buff.ly/ZBPALSk

Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/UvjkAwK

The first immunotherapy approach to treat locally advanced rectal cancer has been approved for use. buff.ly/DeLRObj

Doctors usually wait for cancer to appear before transplanting bone marrow in patients living with Shwachman-Diamond syndrome, a rare genetic disease. New data suggest that may be too late. buff.ly/nlGNFiV

Scientists discover that combination therapy delays recurrent prostate cancer in patients. buff.ly/MdXx8IP

Researchers incorporate a genetic 'switch' to enhance precision and efficacy in CAR-T cell immunotherapy. buff.ly/bOK38n3

Scientists discovered a novel mechanism that helps explain why acute myeloid leukemia is so aggressive. This finding can help better inform therapeutic approaches and enhance treatment outcomes. buff.ly/R6vbXjl

See how 3D spheroid models and live-cell analysis were used to profile 880 FDA-approved compounds, uncovering cytotoxic, cytostatic, and disruptive responses. Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation. buff.ly/qX19AVC

A new study found that less than 40% of Medicaid enrollees with ER+/HER2- breast cancer receive clinically indicated molecular profiling. buff.ly/n7bgzNH

Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh

A new study demonstrates a new technique to detect bladder cancer and predict patients who will respond to different treatments. buff.ly/XbePHGo

Scientists find a way to improve immune cell detection of pediatric brain cancer. buff.ly/lWBx4ga

Colorectal cancer in young patients can be especially aggressive, with new research finding that nearly all patients in a large pediatric study had advanced-stage disease at diagnosis. buff.ly/9yQwRrZ

🧬🔬 Share your science with the world at Labroots’ 2026 CRISPR Virtual Event Series on October 28, 2026. Submit your poster and gain global visibility! ⏰ Deadline: October 23 at 5:00 pm PT 👉 Submit for free: buff.ly/cAdbeXj #LRcrispr

Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/kbahSQo